Amedeo Anselmi

Amedeo Anselmi

Auto-generated profile, based on publicly available information

Amedeo Anselmi

Department of Thoracic and Cardiovascular Surgery, University Hospital Centre Rennes, Rennes, France

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
GMGrégoire Muller
Grégoire Muller
EFErwan Flecher
Erwan Flecher
GLGuillaume Lebreton
Guillaume Lebreton
CLCharles-Edouard Luyt
Charles-Edouard Luyt
JTJean-Louis Trouillet
Jean-Louis Trouillet
ACAlain Combes
Alain Combes

1 July 2017 in JACC
Verified
Journal Article
Closed access
VAVincent Auffret
Vincent Auffret
TLThierry Lefevre
Thierry Lefevre
EBEric Van Belle
Eric Van Belle
HEHélène Eltchaninoff
Hélène Eltchaninoff
BIBernard Iung
Bernard Iung
TWThierry Waldman
Thierry Waldman

1 March 2004 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
AAAmedeo Anselmi
Amedeo Anselmi
AAAntonio Abbate
Antonio Abbate
FGFabiana Girola
Fabiana Girola
GNGiuseppe Nasso
Giuseppe Nasso
Giuseppe Biondi-ZoccaiGiuseppe Biondi-Zoccai
Giuseppe Biondi-Zoccai
MGMario Gaudino
Mario Gaudino
Cardiac surgery (CS), in particular cardiopulmonary bypass and cardioplegia, have been reported to trigger myocardial inflammation and apoptosis. This surgery-related inflammatory reaction appears to be of extreme complexity with regard to its molecular, cellular and tissue mechanisms. Both experimental and clinical studies have ascertained the role of several hormonal mediators, mitochondria, cardioplegia and extracorporeal circulation temperature, apoptosis and even genetic modulators of damage. However, the correlations between these factors in vivo and post-surgery outcome and prognosis have not yet been systematically investigated. In animal models of myocardial cardioplegia and/or ischemia-reperfusion, experimental drugs such as antioxidants have been documented to provide amelioration of post-intervention cardiac performance and reduction of apoptosis suggesting the possibility of new therapeutic strategies. However, these findings have been only partially confirmed in humans. Moreover, markers for the differential detection of early and late phases of apoptosis are subjects of intense investigations. This review will provide an overview of the major studies about the link between ischemia, myocardial inflammation and apoptosis during and after CS, with particular regard to the markers and methods for apoptosis detection.

1 April 2007 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MCMassimo Chello
Massimo Chello
AAAmedeo Anselmi
Amedeo Anselmi
CSCristiano Spadaccio
Cristiano Spadaccio
GPGiuseppe Patti
Giuseppe Patti
CGCostanza Goffredo
Costanza Goffredo
ECElvio Covino
Elvio Covino

1 July 2009 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
AAAmedeo Anselmi
Amedeo Anselmi
GPGianfederico Possati
Gianfederico Possati
MGMario Gaudino
Mario Gaudino

16 October 2007 in Circulation
Verified
Journal Article
Closed access
PDF file
VMValerio Mazzei
Valerio Mazzei
GNGiuseppe Nasso
Giuseppe Nasso
GSGiovanni Salamone
Giovanni Salamone
FCFilippo Castorino
Filippo Castorino
ATAntonello Tommasini
Antonello Tommasini
AAAmedeo Anselmi
Amedeo Anselmi
Background— We aimed to evaluate the clinical results and biocompatibility of the minimal extracorporeal circulation system (MECC) compared with off-pump coronary revascularization (OPCABG).